| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 7 | 71 | 3 | 3 | 4 | 3 | 91 | ||
| OG | 30 | 51 | 0 | 4 | 4 | 2 | 91 | ||
| OD + OG | 37 | 122 | 3 | 7 | 8 | 5 | 182 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 7,69% | 78,02% | 3,30% | 3,30% | 4,40% | 3,30% | 100,00% | ||
| OG | 32,97% | 56,04% | 0,00% | 4,40% | 4,40% | 2,20% | 100,00% | ||
| MOYENNE | 20,33% | 67,03% | 1,65% | 3,85% | 4,40% | 2,75% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 6 | 42 | 2 | 1 | 3 | 1 | 55 | ||
| 10,91% | 76,36% | 3,64% | 1,82% | 5,45% | 1,82% | 100,00% | |||
| FEMMES | 1 | 25 | 1 | 4 | 3 | 2 | 36 | ||
| 2,78% | 69,44% | 2,78% | 11,11% | 8,33% | 5,56% | 100,00% | |||
| TOTAL | 7 | 67 | 3 | 5 | 6 | 3 | 91 | ||
| 7,69% | 73,63% | 3,30% | 5,49% | 6,59% | 3,30% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||